Monthly Archives: September 2013

Making CNS Pay Off

In preparing the October issue of NeuroPerspective, we noted that September was another solid month for the neuroscience stock sector, with a number of companies showing dramatic valuation gains. In fact, the index was up over 11% in just the … Continue reading

Posted in Big Pharma, BioFollies, Biotech | Tagged , , | Leave a comment

Fear and Loathing in Las Vegas*: The Persistence of Gonzo Neuroscience

Like a chronic gambler who keeps thinking that the next time will turn out different, the pharma industry has developed a nasty habit of sidling back to the Alzheimer’s roulette table, putting all their chips on 7, and watching forlornly … Continue reading

Posted in Big Pharma, BioFollies | Tagged , , | Leave a comment